MARIE CURIE CANCER CARE has a total of 22 patent applications. Its first patent ever was published in 1996. It filed its patents most often in United States, Australia and EPO (European Patent Office). Its main competitors in its focus markets biotechnology, pharmaceuticals and machines are SHANGHAI HRAIN BIOTECHNOLOGY CO LTD, NBE THERAPEUTICS LLC and BIOTECH RES PARTNERS LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 7 | |
#2 | Australia | 4 | |
#3 | EPO (European Patent Office) | 3 | |
#4 | Canada | 2 | |
#5 | United Kingdom | 2 | |
#6 | WIPO (World Intellectual Property Organization) | 2 | |
#7 | Brazil | 1 | |
#8 | Mexico | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Machines | |
#4 | Measurement |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Peptides | |
#3 | Medical preparations | |
#4 | Therapeutic chemical compounds | |
#5 | Unspecified technologies | |
#6 | Measuring microorganism processes | |
#7 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | O'Hare Peter Francis Joseph | 17 |
#2 | Elliott Gillian Daphne | 15 |
#3 | Goding Colin Ronald | 2 |
#4 | Normand Nadia Michelle | 1 |
#5 | O'Hare Peter Francis J | 1 |
#6 | Elliot Gillian Daphne | 1 |
#7 | Elliott Gillian D | 1 |
Publication | Filing date | Title |
---|---|---|
AU8150401A | Fusion proteins for intracellular and intercellular transport and their uses | |
EP1159441A2 | Delivery of nucleic acids and proteins to cells | |
GB9925617D0 | Materials and methods relating to the modification of the effects of transcription factors | |
GB9902776D0 | Materials and methods relating to a cancer cell marker | |
US6017735A | Materials and methods for intracellular transport and their uses | |
AU6623996A | Transport proteins and their uses |